Captis Biotechnology, Inc. is a diagnostics company with the mission of commercializing discoveries that address major challenges in disease and pharmaceutical detection and monitoring. The technologies developed by Captis research and diagnostics are towards the treatment of chronic diseases such as cancer, cardiovascular and Alzheimer’s.
Robert M. Strongin, Ph.D.
CEO & President
Captis Biotechjnology is a diagnostics company based in Portland, Oregon. The team includes two Ph.D. scientists with over 20 patents and two companies.
Dr. Robert M. Strongin
2828 SW Corbett Avenue Suite 211A
Portland, OR, 97201, USA